Sir
We concur with Dackis and O'Brien's view that prefrontal cortex dysfunction represents a cardinal feature of cocaine abuse. Although in vivo recordings from our and others laboratories (Chang et al, 1997 (Chang et al, , 1998 (Chang et al, , 2000 implicate a common set of changes in electrophysiological indices in prefrontal cortex neurons after acute and chronic stimulant exposure, the precise synaptic mechanisms mediating these alterations remain unknown. We therefore emphasize the probable dependence of complex psychopathologic features of addiction on the canonical cortico-striatal-pallidothalamo-cortical loops that are clearly implicated in many aspects of cognitive, motor, and affective function (Haber, 2003) , and that are direct mediators of recidivism-like phenomena (Kalivas and Volkow, 2005) .
Elegant work by Steriade and colleagues (Steriade and Deschenes, 1984; Steriade and Timofeev, 2003) indicates that thalamic inputs to the neocortex as well as corticocortical connections (Timofeev et al, 2000) are important regulators of spike activity, as well as of the bistable membrane potentials recorded from prefrontal neurons in vivo. When taken together with the growing evidence for direct actions of stimulant drugs on pallidal and thalamic neurons (Lavin and Grace, 1998) , it becomes apparent that subcortical actions of addictive agents could disrupt cortical neuron function either directly or through complex multisynaptic actions. Indeed, Jentsch and Taylor (1999) have emphasized how drug effects on multiple cortical and subcortical brain regions may be required to sustain the compulsive aspects of drug addiction. We therefore additionally stress these larger circuit actions of stimulant drugs in the key psychological features of addiction noted by Dackis and O'Brien.
Much remains unknown about the subcellular causes of dysfunction of these neuronal loops. New work has emphasized mechanism implicating LTP (Borgland et al, 2004; Saal et al, 2003; Ungless et al, 2001) , intracellular signaling proteins (Szumlinski et al, 2004; Bowers et al, 2004; Nestler, 2004) , and monoamine neurotransmitters (Volkow et al, 2004) . In vivo recordings will be but part of the experimental repertoire required to reveal these changes.
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